InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Klinsmann PremiumMember
08/08/19 11:45 AM
profile icon
wesley_ PremiumMember
08/08/19 11:00 AM
profile icon
Aweiner Free
05/02/19 10:50 AM
profile icon
Klinsmann PremiumMember
02/14/19 12:44 PM
profile icon
Klinsmann PremiumMember
12/01/18 9:10 AM
profile icon
Klinsmann PremiumMember
11/23/18 10:31 AM
profile icon
ZLAZARUS Free
11/14/18 6:46 PM
profile icon
ZLAZARUS Free
11/03/18 1:30 AM
profile icon
ZLAZARUS Free
08/09/18 2:54 PM
profile icon
Vector93 Free
08/09/18 12:29 PM
profile icon
ZLAZARUS Free
07/22/18 1:22 PM
profile icon
ClayTrader Free
07/17/18 5:10 PM
profile icon
ZLAZARUS Free
07/06/18 10:00 PM
profile icon
ZLAZARUS Free
07/02/18 9:35 AM
profile icon
ZLAZARUS Free
07/01/18 7:03 PM
profile icon
ZLAZARUS Free
07/01/18 6:43 PM
profile icon
ZLAZARUS Free
06/30/18 2:26 AM
profile icon
ClayTrader Free
06/29/18 5:13 PM
profile icon
airahim Free
06/29/18 3:38 PM
profile icon
keekee Free
06/28/18 2:07 PM
profile icon
keekee Free
06/28/18 10:56 AM
profile icon
keekee Free
06/28/18 10:25 AM
profile icon
keekee Free
06/28/18 10:22 AM
profile icon
420man Free
06/28/18 8:05 AM
profile icon
~MulaGreen~ Free
06/27/18 1:53 PM
profile icon
KOmani Free
06/27/18 10:30 AM
profile icon
diegonalesso Free
01/10/17 2:28 AM
profile icon
Options2Wealth Grandfathered
01/10/17 2:20 AM
profile icon
kingsransome Free
09/19/16 6:34 PM
profile icon
kingsransome Free
09/14/16 10:07 AM
profile icon
crudeoil24 PremiumMember
09/13/16 11:02 AM
profile icon
ven69 Free
09/02/16 9:23 AM

Aquinox Pharmaceuticals, Inc. (AQXP) RSS Feed

Followers
46
Posters
204
Posts (Today)
0
Posts (Total)
1125
Created
09/30/14
Type
Free
Moderators
Aquinox Pharmaceuticals Inc., a clinical stage pharmaceutical company, discovers and develops oral drug candidates for the treatment of inflammatory diseases and cancer. The company primarily focuses on anti-inflammatory product candidates targeting SHIP1, a key regulator of a cellular signaling pathway in immune cells. Its principal product candidate is AQX-1125, a SHIP1 activator, which is in Phase II clinical trials for chronic obstructive pulmonary disease and bladder pain syndrome/interstitial cystitis. The company was formerly known as 6175813 Canada Inc. and changed its name to Aquinox Pharmaceuticals Inc. in March 2006. Aquinox Pharmaceuticals Inc. was founded in 2003 and is headquartered in Vancouver, Canada. http://www.aqxpharma.com/
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
AQXP Latest News
  • No Recent News Available for this company!
New Post